PALISADE BIO, INC.

PALI Nasdaq CIK: 0001357459

Company Information

Industry Biological Products, (No Diagnostic Substances)
SIC Code 2836
Entity Type operating
SEC Category Non-accelerated filerSmaller reporting company
State of Incorporation DE
Business Address 7750 EL CAMINO REAL, SUITE 5200, CARLSBAD, CA, 92009
Mailing Address 7750 EL CAMINO REAL, SUITE 5200, CARLSBAD, CA, 92009
Phone (858) 704-4900
Fiscal Year End 1231
EIN 522007292

Financial Overview

FY2025

-$14.44M
Net Income

Recent SEC Filings

Form Type Date Filed Document
8-K Current report of material events April 2, 2026 View on SEC
10-K Annual financial report March 20, 2026 View on SEC
SCHEDULE 13G/A Passive ownership amendment February 17, 2026 View on SEC
SCHEDULE 13G/A Passive ownership amendment February 17, 2026 View on SEC
SCHEDULE 13G/A Passive ownership amendment February 17, 2026 View on SEC
SCHEDULE 13G/A Passive ownership amendment February 17, 2026 View on SEC
4 Insider stock transaction report February 13, 2026 View on SEC
SCHEDULE 13G/A Passive ownership amendment February 13, 2026 View on SEC
4 Insider stock transaction report February 13, 2026 View on SEC
4 Insider stock transaction report February 11, 2026 View on SEC

Annual Reports

10-K March 20, 2026
  • PALI-2101 Phase 2 trial for ulcerative colitis fully enrolled 150 patients ahead of schedule by September 2025.
  • Secured $15.0 million in financing in July 2025 to fund operations and clinical development.
View Analysis

Insider Trading

BUY 3 insiders 4 recent transactions
View Full Insider Trading Profile

Related Companies

Companies in the same industry (SIC: 2836)

Investor Resources

Learn more about SEC filings and how to research public companies.

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.